HomePharmaceutical and Medicine Manufacturing > In-Vitro Diagnostic Substance Manufacturing

In-Vitro Diagnostic Substance Manufacturing (NAICS 325413) Industry Market Research Report

In-Vitro Diagnostic Substance Manufacturing - Market Size and Forecast

The In-Vitro Diagnostic Substance Manufacturing report contains both historical and forecasted statistics. Total market size figures from 2015 to 2025 reveal industry growth patterns and trends. Market size measurements include both public and private companies in the industry.

Market Size (Total Revenue)

Included in Report

% Growth Rate
Number of Companies
Total Employees
Average Revenue per Company
Average Employees per Company
Source: U.S. government financial data.

Industry Revenue ($ Billions)

In-Vitro Diagnostic Substance Manufacturing Industry Revenue
  • 2015
  • 2016
  • 2017
  • 2018
  • 2019
  • 2020
  • 2021

Advanced econometric models forecast five years of industry growth based on short- and long-term trend analysis. Market size includes revenue generated from all products and services sold within the industry.

In-Vitro Diagnostic Substance Manufacturing - Geographic Breakdown by U.S. State

Market size by state reveals local opportunity through the number of companies located in the region. Each state's growth rate is affected by regional economic conditions. Data by state can be used to pinpoint profitable and nonprofitable locations for In-Vitro Diagnostic Substance Manufacturing companies in the United States.

In-Vitro Diagnostic Substance Manufacturing Revenue by State

US Market Size by State

Distribution by Company Size

Company SizeAll IndustriesIn-Vitro Diagnostic Substance Manufacturing
Small Business (< 5 Employees)


Small Business (5 - 20)
Midsized Business (20 - 100)
Large Business (100 - 500)
Enterprise (> 500)

In-Vitro Diagnostic Substance Manufacturing - Income Statement (Average Financial Metrics)

Financial statement analysis determines averages for the following industry forces:
The report includes a traditional income statement from an "average" company (both public and private companies included).

Industry AveragePercent of Sales
Total Revenue


Operating Revenue
Cost of Goods Sold (COGS)
Gross Profit
Operating Expenses
Operating Income
Non-Operating Income
Earnings Before Interest and Taxes (EBIT)
Interest Expense
Earnings Before Taxes
Income Tax
Net Profit

Average Income Statement

Average Income Statement

Cost of Goods Sold

Salaries, Wages, and Benefits



Depreciation and Amortization

Officer Compensation

Net Income

In-Vitro Diagnostic Substance Manufacturing - Financial Ratio Analysis

Financial ratios allow a company's performance to be compared against that of its peers.

Financial RatioIndustry Average
Profitability Ratios


Profit Margin
Liquidity Ratios
Current Ratio
Quick Ratio
Activity Ratios
Average Collection Period
Asset Turnover Ratio
Receivables Turnover Ratio
Inventory Conversion Ratio

In-Vitro Diagnostic Substance Manufacturing - Product Mix

Product DescriptionDescriptionRevenue
($ Millions)

In-vitro diagnostic substance manufacturing


In-vitro diagnostic substances

In vitro diagnostic substances, nsk, total

In vitro diagnostic substances, nsk, administrative-records

In-Vitro Diagnostic Substance Manufacturing - Compensation and Salary Surveys

TitlePercent of WorkforceBottom QuartileAverage (Median) SalaryUpper Quartile
Management Occupations11%


Chief Executives0%
General and Operations Managers2%
Business and Financial Operations Occupations8%
Business Operations Specialists7%
Architecture and Engineering Occupations6%
Life, Physical, and Social Science Occupations16%
Life Scientists6%
Physical Scientists6%
Chemists and Materials Scientists6%
Office and Administrative Support Occupations8%
Production Occupations32%
Other Production Occupations26%
Packaging and Filling Machine Operators and Tenders9%
Packaging and Filling Machine Operators and Tenders9%

Government Contracts

In 2008, the federal government spent a total of $184,699,470 on the in-vitro diagnostic substance manufacturing industry. It has awarded 4,677 contracts to 256 companies, with an average value of $721,482 per company.

In-Vitro Diagnostic Substance Manufacturing and Adjacent Industries - Top Companies

($ Millions)


In-Vitro Diagnostic Substance Manufacturing Industry Report
GeographyUnited States  
Publication DateSeptember 2020
Report FormatPDF Download  

Related Market Research Reports

Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing
In-Vitro Diagnostic Substance Manufacturing
Biological Product Manufacturing